Nivolumab plus ipilimumab can provide long-term benefits to patients with advanced melanoma, according to a 10-year update of the CheckMate 067 trial.

Retifanlimab improved upon standard chemotherapy in patients with locally recurrent or metastatic anal cancer in a phase 3 ...

Adding radium-223 to treatment with enzalutamide and a bone-protecting agent improved rPFS and OS in patients with mCRPC and ...

A wide selection of therapies are available to treat advanced prostate cancer, but the optimal treatment strategy is unknown.

Incorporating perioperative durvalumab into treatment with neoadjuvant chemotherapy and radical cystectomy prolongs EFS and OS in patients with MIBC.

Updated results from the INWORKS study “show the importance of adherence to the basic principles of radiation protection,” according to researchers.

The latest federal data shows the rate of new breast cancer diagnoses in Asian American and Pacific Islander women is rising ...

Socioeconomic disparities may impact immunotherapy use in patients with advanced renal cell carcinoma or urothelial carcinoma.

Lesbian, gay, and bisexual cancer survivors have higher odds of severe psychological distress than heterosexual cancer survivors, data suggest.

Women are less likely to return for subsequent breast cancer screening after false-positive results, a study suggests.

New research suggests that a majority of patients with endometrial cancer may have tumors with a HER2 score of 2+ or higher.

Women with hepatocellular carcinoma are less likely to receive a deceased-donor liver transplant and more likely to die while wait-listed.